Michael Anderson
@MedAccessCEO
CEO at @MedAccessUK. Working to ensure fast and equal access to medical products. Because fair access is at the heart of a healthier future.
ID:347341831
http://www.medaccess.org 02-08-2011 17:06:53
2,2K Tweets
7,0K Followers
780 Following
👋 I am delighted to share the news of Cyrus Ardalan’s appointment to the MedAccess Board! The Board will be strengthened by his blend of experience in innovative finance and public health, including with CEPI Gavi, the Vaccine Alliance and Charities Aid Foundation (CAF) Welcome, Cyrus!
Thank you David Cameron and Rt Hon Andrew Mitchell MP for leading Foreign, Commonwealth & Development Office to support access to medicines through MedAccess. With capital from British International Investment this funding will translate directly into affordable treatments for malaria, HIV, and TB
Welcome Senator Dr Sania Nishtar to the helm of Gavi, the Vaccine Alliance and the critical leadership role in advancing immunisation on a global scale. Wishing you the very best from everyone MedAccess and looking forward to future collaboration.
Encouraged to see renewed commitment to innovative finance for health in today’s paper. Thank you David Cameron Rt Hon Andrew Mitchell MP Foreign, Commonwealth & Development Office for efforts to combine best of British science, industry and finance to benefit billions of people, incl through British International Investment investments.
Good to join Sharonann Lynch (@oneillinstitute), Diana Edgil (@USAID) & Robert Matiru (@UNITAID) at World Health Organization (WHO)'s #WLPF2023 . MedAccess is committed to supporting local manufacturing of health products through tailored innovative finance products - such as volume guarantees.
A new mini-case in Financial Times re risk sharing & volume guarantees as a tool to enable global life science companies to better serve underserved markets. It explores some of the decision dilemmas faced by Michael Anderson in its next phase of growth. Thanks Andrew Jack
on.ft.com/3Q0aSgs
“An eye-catching reorganisation is no substitute for long-term planning and thoughtful attention to good management, starting with investing in people and innovation.”
The CEO of MedAccess, Michael Anderson (@MedAccessCEO), speaks to The New Statesman Spotlight ⬇️ newstatesman.com/spotlight/heal…
Genuinely proud of the UK contribution to fighting malaria: GSK and Jenner Institute vaccines, IVCC innovations on nets, MedAccess innovative finance for vaccines, nets, and treatments; world-leading university expertise, and @FCDO funding for The Global Fund Gavi, the Vaccine Alliance